71.19
price up icon0.14%   0.10
after-market Handel nachbörslich: 71.19
loading
Schlusskurs vom Vortag:
$71.09
Offen:
$70.83
24-Stunden-Volumen:
2.96M
Relative Volume:
0.68
Marktkapitalisierung:
$41.85B
Einnahmen:
$5.72B
Nettoeinkommen (Verlust:
$4.17B
KGV:
10.21
EPS:
6.97
Netto-Cashflow:
$259.90M
1W Leistung:
+0.34%
1M Leistung:
-0.29%
6M Leistung:
+6.92%
1J Leistung:
-25.18%
1-Tages-Spanne:
Value
$70.32
$71.56
1-Wochen-Bereich:
Value
$69.82
$72.29
52-Wochen-Spanne:
Value
$58.93
$96.12

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
Firmenname
Edwards Lifesciences Corp
Name
Telefon
(949) 250-2500
Name
Adresse
ONE EDWARDS WAY, IRVINE, CA
Name
Mitarbeiter
0
Name
Twitter
@edwardslifesci
Name
Nächster Verdiensttermin
2025-02-11
Name
Neueste SEC-Einreichungen
Name
EW's Discussions on Twitter

Vergleichen Sie EW mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
EW
Edwards Lifesciences Corp
71.19 41.85B 5.72B 4.17B 259.90M 6.97
Medical Devices icon
ABT
Abbott Laboratories
131.35 227.80B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.80 149.09B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
367.54 142.81B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.98 114.12B 33.20B 4.26B 5.47B 3.29

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-30 Hochstufung Stifel Hold → Buy
2025-01-16 Herabstufung Wolfe Research Peer Perform → Underperform
2024-12-16 Hochstufung BofA Securities Neutral → Buy
2024-10-11 Fortgesetzt Morgan Stanley Equal-Weight
2024-09-18 Herabstufung Jefferies Buy → Hold
2024-07-31 Hochstufung Daiwa Securities Neutral → Outperform
2024-07-29 Hochstufung Wolfe Research Underperform → Peer Perform
2024-07-25 Herabstufung BofA Securities Buy → Neutral
2024-07-25 Herabstufung JP Morgan Overweight → Neutral
2024-07-25 Herabstufung Robert W. Baird Outperform → Neutral
2024-07-25 Herabstufung TD Cowen Buy → Hold
2024-07-25 Herabstufung Truist Buy → Hold
2024-05-30 Eingeleitet Goldman Buy
2024-05-22 Hochstufung Citigroup Neutral → Buy
2024-05-14 Hochstufung Deutsche Bank Hold → Buy
2024-03-07 Hochstufung BofA Securities Neutral → Buy
2024-02-02 Hochstufung Wells Fargo Equal Weight → Overweight
2024-01-04 Herabstufung Evercore ISI Outperform → In-line
2023-12-11 Herabstufung Citigroup Buy → Neutral
2023-11-28 Herabstufung Wolfe Research Peer Perform → Underperform
2023-09-26 Hochstufung Oppenheimer Perform → Outperform
2023-07-19 Eingeleitet Robert W. Baird Outperform
2023-05-30 Fortgesetzt Morgan Stanley Overweight
2023-03-29 Eingeleitet UBS Neutral
2023-03-08 Herabstufung Wells Fargo Overweight → Equal Weight
2023-02-06 Herabstufung Raymond James Outperform → Mkt Perform
2023-01-31 Herabstufung Bernstein Outperform → Underperform
2023-01-30 Herabstufung Piper Sandler Overweight → Neutral
2022-12-06 Herabstufung Stifel Buy → Hold
2022-10-28 Herabstufung Oppenheimer Outperform → Perform
2022-10-26 Eingeleitet Mizuho Buy
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Buy
2022-07-29 Herabstufung Canaccord Genuity Buy → Hold
2022-04-13 Eingeleitet Truist Buy
2022-04-06 Eingeleitet Wolfe Research Outperform
2022-03-16 Hochstufung Bernstein Mkt Perform → Outperform
2022-03-02 Fortgesetzt BofA Securities Neutral
2022-02-02 Hochstufung UBS Neutral → Buy
2022-01-27 Bestätigt Citigroup Buy
2022-01-27 Bestätigt Evercore ISI Outperform
2022-01-27 Bestätigt Raymond James Outperform
2022-01-27 Bestätigt Stifel Buy
2022-01-27 Bestätigt UBS Neutral
2021-12-17 Hochstufung JP Morgan Neutral → Overweight
2021-12-15 Hochstufung Citigroup Neutral → Buy
2021-12-10 Eingeleitet RBC Capital Mkts Outperform
2021-12-06 Hochstufung Wells Fargo Equal Weight → Overweight
2021-07-30 Bestätigt Canaccord Genuity Buy
2021-07-30 Bestätigt Deutsche Bank Hold
2021-07-30 Bestätigt Jefferies Buy
2021-07-30 Bestätigt Morgan Stanley Overweight
2021-07-30 Bestätigt Oppenheimer Outperform
2021-07-30 Bestätigt Stifel Buy
2021-07-30 Bestätigt UBS Neutral
2021-07-30 Bestätigt Wells Fargo Equal Weight
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Neutral
2021-04-05 Hochstufung Evercore ISI In-line → Outperform
2020-12-16 Herabstufung Citigroup Buy → Neutral
2020-12-11 Bestätigt Canaccord Genuity Buy
2020-09-11 Eingeleitet Wolfe Research Underperform
2020-04-28 Herabstufung Wells Fargo Overweight → Equal Weight
2020-04-17 Hochstufung SVB Leerink Mkt Perform → Outperform
2020-03-05 Eingeleitet Citigroup Buy
2020-02-13 Eingeleitet Goldman Neutral
2020-02-06 Fortgesetzt BTIG Research Neutral
2020-01-10 Eingeleitet Oppenheimer Outperform
2020-01-02 Herabstufung Evercore ISI Outperform → In-line
2019-10-24 Bestätigt Canaccord Genuity Buy
2019-09-23 Eingeleitet Piper Jaffray Overweight
2019-07-24 Bestätigt BofA/Merrill Buy
2019-03-18 Bestätigt Canaccord Genuity Buy
2019-01-18 Hochstufung BofA/Merrill Neutral → Buy
2019-01-03 Eingeleitet Deutsche Bank Hold
2018-11-28 Eingeleitet UBS Neutral
2018-10-16 Eingeleitet Barclays Underweight
2018-10-02 Herabstufung BofA/Merrill Buy → Neutral
2018-10-02 Herabstufung Guggenheim Buy → Neutral
Alle ansehen

Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten

pulisher
07:10 AM

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $85 From $92, Keeps Buy Rating - Marketscreener.com

07:10 AM
pulisher
06:55 AM

Goldman Sachs Adjusts Price Target to Edwards Lifesciences to $85 From $92, Keeps Buy Rating - Marketscreener.com

06:55 AM
pulisher
Mar 26, 2025

Edwards Lifesciences CFO Scott Ullem sells $797,267 in stock - Investing.com India

Mar 26, 2025
pulisher
Mar 23, 2025

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead - Seeking Alpha

Mar 23, 2025
pulisher
Mar 18, 2025

S&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key Product - MSN

Mar 18, 2025
pulisher
Mar 17, 2025

How Is The Market Feeling About Edwards Lifesciences? - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Is Edwards Lifesciences Stock Underperforming the Nasdaq? - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Is Edwards Lifesciences Stock Underperforming The Nasdaq? - Barchart

Mar 17, 2025
pulisher
Mar 14, 2025

Edwards Lifesciences downgraded at JPM, Truist on slower transcatheter valve growth - MSN

Mar 14, 2025
pulisher
Mar 13, 2025

Edwards Lifesciences VP Donald Bobo Jr. sells $645,623 in stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Edwards Lifesciences VP Donald Bobo Jr. sells $645,623 in stock - Investing.com

Mar 13, 2025
pulisher
Mar 10, 2025

Edwards Lifesciences CVP Daniel Lippis sells $27,792 in stock By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Edwards Lifesciences CEO Bernard Zovighian sells $428k in stock - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Edwards Lifesciences CVP Daniel Lippis sells $27,792 in stock - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Edwards Lifesciences CEO Bernard Zovighian sells $428k in stock By Investing.com - Investing.com UK

Mar 10, 2025
pulisher
Mar 10, 2025

Edwards Lifesciences Corporation (EW): Among the Top Stocks to Buy According to Citadel Investment Group - Insider Monkey

Mar 10, 2025
pulisher
Mar 08, 2025

Director Heisz Stone Sells Shares of Edwards Lifesciences Corp - GuruFocus.com

Mar 08, 2025
pulisher
Mar 07, 2025

Edwards Lifesciences Corp. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Jefferies maintains hold on Edwards Lifesciences stock, target $71 - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Q2 EPS Forecast for Edwards Lifesciences Cut by Analyst - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Blood Pressure Monitor Market Growth USD 4.36 Billion by 2035 at a 6.1% of CAGR | Future Market Insights, Inc. - GlobeNewswire Inc.

Mar 05, 2025
pulisher
Mar 01, 2025

Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight - GuruFocus.com

Mar 01, 2025
pulisher
Mar 01, 2025

Sabal Trust CO Has $2.23 Million Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Oppenheimer & Co. Inc. Raises Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Truist Financial Corp Buys 6,676 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Impax Asset Management Group plc Increases Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Edwards Lifesciences CFO Scott Ullem sells $796k in stock - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

National Pension Service Cuts Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Edwards Lifesciences Co. (NYSE:EW) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

HealthInvest Partners AB Buys 31,791 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

BankPlus Trust Department Takes $844,000 Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Union Bancaire Privee UBP SA Makes New $1.12 Million Investment in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Hardman Johnston Global Advisors LLC Sells 7,170 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Private Advisor Group LLC Acquires 9,440 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Bank of New York Mellon Corp Has $1.34 Billion Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Catheter Market Global Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, BD and Co, Boston Scientific, Teleflex, Medtronic, Johnson & Johnson, Edwards Lifesciences, Stryker - Yahoo Finance

Feb 26, 2025
pulisher
Feb 26, 2025

A Look Into Edwards Lifesciences Inc's Price Over Earnings - Benzinga

Feb 26, 2025
pulisher
Feb 26, 2025

W.G. Shaheen & Associates DBA Whitney & Co Increases Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 26, 2025
pulisher
Feb 25, 2025

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference - BioSpace

Feb 25, 2025
pulisher
Feb 25, 2025

What Will Edwards Lifesciences Reveal at Next Week's Major Healthcare Conference? - StockTitan

Feb 25, 2025
pulisher
Feb 24, 2025

Edwards Sees ‘Emerging’ Opportunities in Structural Heart Disease - Orange County Business Journal

Feb 24, 2025
pulisher
Feb 23, 2025

FRIDAY INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitEW - ACCESS Newswire

Feb 23, 2025
pulisher
Feb 23, 2025

CIBC Asset Management Inc Sells 31,973 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 23, 2025
pulisher
Feb 21, 2025

Principal Financial Group Inc. Sells 23,591 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Pittenger & Anderson Inc. Grows Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

AlphaCentric Advisors LLC Makes New $691,000 Investment in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Baillie Gifford & Co. Buys 498,100 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Kentucky Retirement Systems Insurance Trust Fund Has $287,000 Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Ownership Capital B.V. Sells 200,754 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Edwards Lifesciences Co. (NYSE:EW) Position Lessened by Chevy Chase Trust Holdings LLC - MarketBeat

Feb 20, 2025

Finanzdaten der Edwards Lifesciences Corp-Aktie (EW)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$81.66
price up icon 0.81%
$69.47
price down icon 3.69%
medical_devices PHG
$25.69
price up icon 2.19%
medical_devices ZBH
$112.15
price up icon 1.36%
medical_devices STE
$224.23
price up icon 0.52%
Kapitalisierung:     |  Volumen (24h):